Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status
{{output}}
Background/aim: The mesenchymal-epithelial transition (MET) receptor plays a key role in cell growth and survival. The MET exon 14 (METex14) skipping mutation occurs in 3% to 4% of patients with non-small cell lung cancer (NSCLC)... ...
